Literature DB >> 27705004

CRP/IL-6/IL-10 Single-Nucleotide Polymorphisms Correlate with the Susceptibility and Severity of Community-Acquired Pneumonia.

Shou-Chu Chou1, How-Wen Ko2, Ying-Chin Lin1.   

Abstract

OBJECTIVE: To explore the associations of single-nucleotide polymorphisms (SNPs) of the C-reactive protein (CRP), interleukin 6 (IL-6) and IL-10 genes with susceptibility and severity of community-acquired pneumonia (CAP).
MATERIALS AND METHODS: Two hundred seventy-nine CAP patients were selected for the case group and 156 healthy individuals for the control group. Polymerase chain reaction-restriction fragment length polymorphism was performed for genotyping of CRP +1059G/C (rs1800947) and +1846C/T (rs1205), IL-6 -597G/A (rs1800797) and -572C/G (rs1800796), and IL-10 -592C/A (rs1800872) and -1082G/A (rs1800896). According to CURB-65 score, the patients were assigned into the severe community-acquired pneumonia (SCAP) and non-SCAP groups.
RESULTS: The frequencies of the CRP +1846C/T (rs1205) (CT+TT) genotypes and T allele, the IL-6 -597G/A (rs1800797) (AA+AG) genotypes and A allele, and the IL-10 -592C/A (rs1800872) (CA+AA) genotypes and A allele were higher in the case group than the control group. Furthermore, the frequencies of the CRP +1846C/T (rs1205) (CT+TT) genotypes and T allele, the IL-6 -597G/A (rs1800797) A allele, and the IL-10 -592C/A (rs1800872) (CA+AA) genotypes and A allele were higher in the SCAP group than in the non-SCAP group.
CONCLUSION: The CRP +1846C/T (rs1205), IL-6 -597G/A (rs1800797), and IL-10 -592C/A (rs1800872) may be associated with the susceptibility and severity of CAP.

Entities:  

Keywords:  CRP +1059G/C; CRP +1846C/T; IL-10 −1082; IL-10 −592C/A; IL-6 −572C/G; IL-6 −597G/A; community-acquired pneumonia; single-nucleotide polymorphism; susceptibility

Mesh:

Substances:

Year:  2016        PMID: 27705004     DOI: 10.1089/gtmb.2016.0156

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  8 in total

Review 1.  A literature review of severity scores for adults with influenza or community-acquired pneumonia - implications for influenza vaccines and therapeutics.

Authors:  Katherine Adams; Mark W Tenforde; Shreya Chodisetty; Benjamin Lee; Eric J Chow; Wesley H Self; Manish M Patel
Journal:  Hum Vaccin Immunother       Date:  2021-11-10       Impact factor: 3.452

2.  The association between Interleukin-6 rs1800795/rs1800797 polymorphisms and risk of rotator cuff tear in a Chinese population.

Authors:  Jin Li; Lifeng Jiang; Xindie Zhou; Lidong Wu; Dong Li; Gang Chen
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

Review 3.  Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll-like receptors dictates pathophysiology of COVID-19 disease.

Authors:  Mohammad Kazem Vakil; Yaser Mansoori; Ghaidaa Raheem Lateef Al-Awsi; Ali Hosseinipour; Samaneh Ahsant; Sedigheh Ahmadi; Mohammad Ekrahi; Zahra Montaseri; Babak Pezeshki; Poopak Mohaghegh; Mojtaba Sohrabpour; Maryam Bahmanyar; Abdolreza Daraei; Tahereh Dadkhah Jouybari; Alireza Tavassoli; Abdolmajid Ghasemian
Journal:  J Med Virol       Date:  2022-05-31       Impact factor: 20.693

4.  Risk factors and coping strategies of severe community-acquired pneumonia in chemotherapy induction period of acute leukemia.

Authors:  Ning Li; Qingcheng Duan; Weidan Zhang
Journal:  Oncol Lett       Date:  2018-01-04       Impact factor: 2.967

5.  Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia.

Authors:  Zulvikar Syambani Ulhaq; Gita Vita Soraya
Journal:  Med Clin (Barc)       Date:  2020-07-10       Impact factor: 1.725

6.  The Effect of lnterleukin-6 Gene Polymorphism on Pediatric Pneumonia.

Authors:  Guode Su; Lili Ding; Zhenkun Zhang
Journal:  Iran J Public Health       Date:  2019-11       Impact factor: 1.429

7.  NACHT, LRR, and PYD domains-containing Protein 3 and LL-37: prognostic value of new biomarkers in community-acquired pneumonia.

Authors:  Chuanan Zhu; Yingfan Zhou; Jiabin Zhu; Ye Liu; Mengyi Sun
Journal:  J Bras Pneumol       Date:  2019-08-29       Impact factor: 2.624

Review 8.  Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment.

Authors:  Laith N Al-Eitan; Saif Z Alahmad
Journal:  Rev Med Virol       Date:  2020-11-17       Impact factor: 11.043

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.